Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan

NCT06482957 is registered in ClinicalTrials.gov with Vanderbilt-Ingram Cancer Center as lead sponsor.

NCT NCT06482957
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06482957 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CAUSAL: Cohort to Augment the Understanding of Sarcoma Survivorship Across the Lifespan
Lead sponsor
Vanderbilt-Ingram Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
April 1, 2022
Completion date
April 30, 2029
Enrollment
2,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sarcoma